Krishna Institute of Medical Sciences Limited

rs,

nager, Department of Corporate Services Bombay Stock Exchange Ltd (BSE) Phiroze Jheejheebhoy Towers, Dalal Street, Mumbai - 400 001. Scrip Code - 543308 ISIN: INE967H01025 Dear Sir, Sub: Investo

Rs. 45,000

entre” in Hyderabad with 50 beds and performed heart surgeries at an unimaginable low cost of just Rs. 45,000 only. Dr. Rao never turned away any patient from the hospital for want of money. The brand “Krishna

rs 6

h as Financial counseling tool which uses AI to help patients with surgery costings among many others 6 Private & Confidential Board of Directors Dr. Bhaskara Rao Bollineni Chairman & Managing Director

7.0%

ector 7 Private & Confidential Shareholding Pattern - As on 31st December, 2024 Retail Pre IPO, 7.0% Retail & Others, 4.3% Promoter & Promoter Group, 38.8% Share Holder Promoter SBI MF HD

4.3%

idential Shareholding Pattern - As on 31st December, 2024 Retail Pre IPO, 7.0% Retail & Others, 4.3% Promoter & Promoter Group, 38.8% Share Holder Promoter SBI MF HDFC MF Axis MF Nomu

38.8%

on 31st December, 2024 Retail Pre IPO, 7.0% Retail & Others, 4.3% Promoter & Promoter Group, 38.8% Share Holder Promoter SBI MF HDFC MF Axis MF Nomura SBI Insurance Vanguard Equ

17.3%

9,366 78,50,000 Amansa Holdings Private Limited 77,04,880 Nippon MF 61,28,230 FII, 17.3% DII, 32.6% No of Shares Share Holding % Category 15,52,56,520 38.8% 7.1% 4.7% 4.4% 2.9%

32.6%

50,000 Amansa Holdings Private Limited 77,04,880 Nippon MF 61,28,230 FII, 17.3% DII, 32.6% No of Shares Share Holding % Category 15,52,56,520 38.8% 7.1% 4.7% 4.4% 2.9% 2.9% 2.4%

7.1%

61,28,230 FII, 17.3% DII, 32.6% No of Shares Share Holding % Category 15,52,56,520 38.8% 7.1% 4.7% 4.4% 2.9% 2.9% 2.4% 2.3% 2.0% 1.9% 1.5% DII DII DII FII DII FII D

4.7%

,230 FII, 17.3% DII, 32.6% No of Shares Share Holding % Category 15,52,56,520 38.8% 7.1% 4.7% 4.4% 2.9% 2.9% 2.4% 2.3% 2.0% 1.9% 1.5% DII DII DII FII DII FII DII

4.4%

FII, 17.3% DII, 32.6% No of Shares Share Holding % Category 15,52,56,520 38.8% 7.1% 4.7% 4.4% 2.9% 2.9% 2.4% 2.3% 2.0% 1.9% 1.5% DII DII DII FII DII FII DII DII

2.9%

17.3% DII, 32.6% No of Shares Share Holding % Category 15,52,56,520 38.8% 7.1% 4.7% 4.4% 2.9% 2.9% 2.4% 2.3% 2.0% 1.9% 1.5% DII DII DII FII DII FII DII DII FII

“Best Super-Specialty Hospital in Telangana National Quality Excellence Awards 2020 Only Hospital in Telangana to get NABH Accredition for Emergency Department 2021 Ranked No.1 in Hyderabad for Cardiology, Neurosciences, Nephrology & Emergency Times Health Survey Times of India 13 Private & ConfidentialINTERNATIONAL ACCREDITATION Consistent Performer over 2 decades (Rupees in Millions) 25,112 22,235 6,232 5,766 CAGR: 27.1% 11,287 16,711 CAGR: 30.1% 5,217 2,412 263 2005 No.”

“• PAT at INR 93 Cr in Q3 FY25 against INR 77 Cr and INR 121 Cr in Q3 FY24 and Q2 FY25 respectively.”

“• Cash and Cash Equivalents (includes Cash, Bank balance, Deposits with maturity less than 12 months and Investment in Mutual funds) at INR 112 Cr as on Q3 FY25.”

“• Consolidated Key Financials figures are as follows (Rs in Cr) : Particulars Total Income Less : Other Income Revenue from Operations PBT Add : Interest Add : Depreciation Consoldiated - FY25 Q3 Results Q3 FY24 Q2 FY25 Q3 FY25 QoQ YoY 609.1 3.3 605.8 102.4 12.4 35.4 782.3 5.0 777.3 162.2 19.9 41.0 790.2 17.8 772.4 134.6 25.7 44.7 -0.6% -17.0% 27.5% 31.4% Reported EBITDA (Incl.”

VISION

1

OUR MISSION

1

About Kollam

1

Competitive Landscape

1

About the Hospital

1

Operational Parameters

1

VISION

To be the most preferred healthcare services brand by providing affordable care and best clinical outcomes to patients. And to be the best place to work for doctors and employees.

OUR MISSION

Provide affordable quality care to our patients with patient-centric systems and processes. Enable clinical outcome-driven excellence by engaging modern medical technology. Provide a strong impetus for doctors to pursue academics and medical research. S T N ATIE P Most Preferred Healthcare Provider DOCTORS EMPLOYEES INVESTO RS Affordable Quality Care Best-in-Class Facilities Patient Centric Systems & Processes Clinical Outcome Driven Excellence Latest Medical Technology Strong Academics & Research Oriented Enriching Atmosphere Collaborative Culture Growth Driven Career Approach Transparent Governance Strong Operational Performance Consistent Growth 2 Private & Confidential Multi Specialty Care Brain • Neurology • Neurosurgery • Psychiatry • Neuro Rehabilitation Heart • Cardiology • Cardiac Surgery • Vascular Surgery • Heart Transplant • Cardio Rehabilitation Lung • Pulmonology • Interventional Pulmonology • Thoracic surgery • Lung Transplant ENT • Ear • Nose • Throat • Head and Neck Su

About Kollam

Kollam, is an ancient seaport and the fourth largest city in the Indian state of Kerala. Located on the southern tip of the Malabar Coast of the Arabian Sea, the city is on the banks of Ashtamudi Lake and is 71 kms northwest of the Thiruvananthapuram. As per the survey conducted by the Economist Intelligence Unit (EIU) based on urban area growth during January 2020, Kollam became the tenth fastest growing city in the world with a 31.1% urban growth between 2015 and 2020.

About the Hospital

This is a 350 – bedded Multi-Speciality Hospital. Currently, the hospital has 3 Acres 70 Cents of land with a built-up area of 2.26 lacs sqft. • 326 Census Beds • 24 Non Census beds • 5 OTs • 1 CathLab • 1 MRI • 1 CT

Operational Parameters

ARPOB - 16,000 Key Existing Specialities - Orthopedics, Gynaecology & Pediatrics Proposed Specialities to be added - Cardiology, Internal Medicine, Neuro Surgery, Neurology, Nephrology, Urology, Medical & Surgical Gastroenterology and General Surgery 29 Private & Confidential Nashik Unit - Now fully operational 30 Private & Confidential Profit and Loss Statement (Rupees in Millions) Particulars Consolidated Q3 FY24 Q2 FY25 Q3 FY25 QoQ(%) YoY(%) 9M FY24 9M FY25 YoY(%) Operating Revenue 6,058 7,773 7,724 -0.6% 27.5% 18,643 22,381 20.1% Other Income Total Revenue EBITDA 33 6,091 1,503 50 178 256.0% 439.4% 92 274 197.8% 7,823 2,231 7,902 2,050 1.0% -8.1% 29.7% 18,735 22,655 36.4% 4,906 6,121 20.9% 24.8% EBITDA (%) on total revenue 24.7% 28.5% 25.9% 26.2% 27.0% PBT 1,024 1,622 1,346 -17.0% 31.4% 3,596 4,240 17.9% PBT (%) on total revenue 16.8% 20.7% 17.0% 19.2% 18.7% PAT 765 1,207 925 -23.4% 20.9% 2,645 3,087 16.7% PAT (%) on total revenue 12.6% 15.4% 11.7% 14.1% 13.6% Basic EPS(Rs.) Dilute